Scopus:
Novel asymmetric biscarbothioamides as Alzheimer's disease associated cholinesterase inhibitors: synthesis, biological activity, and molecular docking studies

dc.contributor.authorMuğlu H.
dc.contributor.authorYakan H.
dc.contributor.authorErdoğan M.
dc.contributor.authorTopal F.
dc.contributor.authorTopal M.
dc.contributor.authorTürkeş C.
dc.contributor.authorBeydemir Ş.
dc.date.accessioned2024-06-27T05:57:33Z
dc.date.available2024-06-27T05:57:33Z
dc.date.issued2024-06-03
dc.identifier10.1039/d4nj01462f
dc.identifier.doi10.1039/d4nj01462f
dc.identifier.issn11440546
dc.identifier.scopus2-s2.0-85195081063
dc.identifier.urihttps://hdl.handle.net/20.500.12597/33331
dc.relation.ispartofNew Journal of Chemistry
dc.relation.ispartofseriesNew Journal of Chemistry
dc.rightsfalse
dc.titleNovel asymmetric biscarbothioamides as Alzheimer's disease associated cholinesterase inhibitors: synthesis, biological activity, and molecular docking studies
dc.typeJournal
dspace.entity.typeScopus
oaire.citation.issue24
oaire.citation.volume48
person.affiliation.nameKastamonu University
person.affiliation.nameOndokuz Mayis Üniversitesi
person.affiliation.nameKafkas Üniversitesi
person.affiliation.nameGümüşhane Üniversitesi
person.affiliation.nameGümüşhane Üniversitesi
person.affiliation.nameErzincan Binali Yıldırım Üniversitesi
person.affiliation.nameAnadolu Üniversitesi
person.identifier.orcid0000-0002-4428-4696
person.identifier.orcid0000-0001-6097-2862
person.identifier.orcid0000-0002-2443-2372
person.identifier.scopus-author-id56195892800
person.identifier.scopus-author-id46462159400
person.identifier.scopus-author-id57195289179
person.identifier.scopus-author-id35811768400
person.identifier.scopus-author-id55929192400
person.identifier.scopus-author-id55857860900
person.identifier.scopus-author-id6603903192

Files